10-Q: PreAxia Health Reports Q1 Loss Amid Development Spend

PreAxia Health Care Payment Systems Inc. reported a significant net loss in Q1 2026 as it ramps up development and capitalizes on non-cash equity financing.

Summary

• Net comprehensive loss increased significantly to $874,906 for the three months ended August 31, 2025, compared to $4,627 for the same period in 2024.
• Operating expenses surged to $875,203 from $4,627 year-over-year, driven by increased consulting, research and development, and management costs.
• The company generated no revenue during both the current and prior year periods.
• Cash and cash equivalents increased to $130,285 as of August 31, 2025, from $0 at May 31, 2025.
• Working capital deficit improved substantially to ($232,678) from ($2,341,169) over the quarter, primarily due to debt conversion and stock subscriptions.
• Shareholders' equity turned positive to $427,322 from a deficit of ($2,341,169) at May 31, 2025.
• Accumulated deficit grew to ($6,085,524) from ($5,210,390) at May 31, 2025.
• The company issued stock subscriptions totaling $3,651,222 for cash, services, and debt conversion during the quarter.
• Substantial doubt exists about the company's ability to continue as a going concern without additional capital.

Sentiment

Score: 3

Explanation: While the company significantly improved its working capital and shareholders' equity through non-cash transactions (debt-to-equity conversions and stock for services), and raised some cash, the substantial increase in net loss and operating expenses with zero revenue indicates a high burn rate for a development-stage company. The explicit 'going concern' warning and ineffective disclosure controls are significant negatives. The positive financial metrics are largely due to accounting reclassifications rather than operational profitability.

Positives

• Cash and cash equivalents increased to $130,285 as of August 31, 2025, from $0 at May 31, 2025.
• Working capital deficit significantly improved to ($232,678) as of August 31, 2025, from ($2,341,169) as of May 31, 2025.
• Shareholders' equity turned positive to $427,322 as of August 31, 2025, from a deficit of ($2,341,169) as of May 31, 2025.
• Successfully converted $1,643,397 in related party debt and other loans into stock subscriptions, reducing liabilities.
• Secured $200,000 in cash from a private placement of 800,000 common shares.
• Established two new subsidiaries, Zane Inc. CA and Zane Inc. US, to expand development and marketing of personal financial management products and healthcare payment processing services.

Negatives

• Reported a net comprehensive loss of $874,906 for the three months ended August 31, 2025, a significant increase from $4,627 in the prior year period.
• Total operating expenses surged to $875,203 for the quarter, up from $4,627 in the comparable prior year period, indicating a substantial increase in burn rate without corresponding revenue.
• The company generated no revenue during the reporting period, highlighting its early development stage and lack of commercialized products.
• Accumulated deficit increased to ($6,085,524) as of August 31, 2025, from ($5,210,390) at May 31, 2025.
• Cash used in operating activities increased to $74,801 for the quarter, up from $2,396 in the prior year period.
• Management concluded that disclosure controls and procedures were not effective as of August 31, 2025.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to a lack of significant cash, material assets, operations, or revenue sufficient to cover operating costs.
• The company's continuation is dependent upon its ability to develop additional sources of capital and ultimately achieve profitable operations.
• There is no assurance that the company will be successful in attracting suitable investors or obtaining additional financing.
• Additional financing, if obtained, may contain undue restrictions on operations (debt financing) or cause substantial dilution for shareholders (equity financing).
• There is a risk of being forced to scale down or cease business operations if additional financing is not obtained on a timely basis.
• Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause actual results to be materially different from expectations.
• Risks include international, national, and local general economic and market conditions; demographic changes; the ability to sustain, manage, or forecast growth; the ability to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; and the ability to protect technology.

Future Outlook

The company plans to raise additional capital, penetrate healthcare processing markets in Canada, the United States, and worldwide, build strategic alliances, and fill senior management, sales, administrative, and engineering positions over the next twelve months. It projects needing an estimated $1,000,000 over the next twelve months to cover arms-length creditors and complete its business plan.

Management Comments

• The company's ability to continue as a going concern is dependent upon its ability to develop additional sources of capital and to ultimately achieve profitable operations.
• Currently, the company does not have significant cash or other material assets, nor does it have operations or a source of revenue sufficient to cover its operating costs and allow it to continue as a going concern.
• The company hopes to be able to attract suitable investors for its business plan, which will not require the use of its cash.
• There can be no assurance that the company will be successful in this situation.
• We project that we will require an estimated $1,000,000 over the next twelve-month period to pay our arms-length creditors approximately $300,000 plus an additional $700,000 to complete our business plan.

Industry Context

The company operates in the emerging health payment market, specifically targeting Health Spending Accounts (HSA) and consumer-directed healthcare. This market is experiencing rapid growth, with HSAs in the US reaching $122.8 billion in assets in 2023 and 33.9 million consumers in 2022, an increase of over 11% in assets year-over-year. The company intends to initially launch products in Canada, believing Canadian businesses are embracing new healthcare financing vehicles. The blurring boundaries between healthcare and financial services create significant opportunities for innovative payment solutions.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Related Party Transactions

• Tom Zapatinas (CEO, Director) had accrued officer compensation of $420,000 as of August 31, 2025, and advances payable of $100,438.
• Pavel Bondarev (Director, CEO of Zane Inc.) had accrued officer compensation of $12,661 as of August 31, 2025.
• Tom Zapatinas earned $30,000 for consulting services during the three months ended August 31, 2025.
• Pavel Bondarev earned $20,000 for management services during the three months ended August 31, 2025.
• On June 30, 2025, Tom Zapatinas' promissory note of $466,817 and convertible note payable of $1,058,760 were converted into stock subscriptions.
• Pavel Bondarev received a stock subscription worth $660,000 for management services.

Stakeholder Impact

• Shareholders face significant dilution risk from future equity financing. Current shareholders' equity turned positive due to non-cash transactions, but accumulated deficit increased. The 'going concern' warning poses a substantial risk to investment value.
• Employees/Contractors, particularly key personnel like Tom Zapatinas and Pavel Bondarev, are compensated through accrued salaries and stock subscriptions, indicating reliance on equity for compensation.
• Creditors have seen some debt converted to equity, reducing immediate liabilities, but the company still needs to raise $300,000 for arms-length creditors. The 'going concern' warning suggests risk for remaining creditors.
• Customers are not directly impacted yet as products are in the development stage, but future success depends on market acceptance of these products.

Next Steps

• Raise additional capital to execute business plans.
• Penetrate healthcare processing markets in Canada, the United States, and worldwide.
• Build a network of strategic alliances with health insurance companies, governments, and other vertical markets.
• Fill senior management, sales, administrative, and engineering positions.
• Develop and market personal financial management products and perfect healthcare payment processing services through Zane Inc. CA and Zane Inc. US.
• Create procedures to assess, identify, and manage material risks from cybersecurity threats in the upcoming year.

Key Dates

Recommendation

The company is in a very early development stage with zero revenue and a rapidly increasing net loss and operating expenses. While the balance sheet shows an improvement in shareholders' equity and working capital, this is largely due to non-cash conversions of debt and services into equity, rather than operational profitability or significant cash generation. The explicit 'going concern' warning, coupled with the admission of ineffective disclosure controls, signals severe financial instability and high operational risk. The need for substantial additional capital with no assurance of obtaining it, and the potential for significant shareholder dilution, makes this a highly speculative and risky investment. A seasoned investor would likely avoid or exit this position due to the fundamental weaknesses and uncertainties.

Keywords

Healthcare Payment Systems, Personal Financial Management, Health Savings Accounts, HSA, Fintech, Software Development, Startup, SEC Filing, 10-Q, PreAxia, Zane Inc, Financial Technology, Digital Health